Filing Manager
PERCEPTIVE ADVISORS LLC
Reporting Manager
Perceptive Advisors LLC
Symbol
SLDB
Shares outstanding
92,783,558 shares
Disclosed Ownership
11,969,079 shares
Ownership
13%
Form type
SCHEDULE 13D/A
Filing time
11 Mar 2026, 16:00:06 UTC
Date of event
09 Mar 2026
Previous filing
21 Feb 2025

Quoteable Key Fact

"PERCEPTIVE ADVISORS LLC disclosed 13% ownership in Solid Biosciences Inc. Common Stock, $0.001 par value per share (SLDB) on 09 Mar 2026."

Quick Takeaways

  • PERCEPTIVE ADVISORS LLC filed SCHEDULE 13D/A for Solid Biosciences Inc. Common Stock, $0.001 par value per share (SLDB).
  • Disclosed ownership: 13%.
  • Date of event: 09 Mar 2026.

What Changed

  • Previous schedule filing date: 21 Feb 2025.
  • Current filing was accepted on 11 Mar 2026, 16:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Perceptive Advisors LLC 13% 11,969,079 0 11,969,079 /s/ Joseph Edelman Joseph Edelman, Managing Member 0001224962
Joseph Edelman 13% 11,969,079 0 11,969,079 /s/ Joseph Edelman Joseph Edelman 0001164426
Perceptive Life Sciences Master Fund, Ltd. 13% 11,895,972 0 11,895,972 /s/ Joseph Edelman Joseph Edelman, Managing Member 0001249675
Perceptive Xontogeny Venture Fund, LP 0.1% 73,107 0 73,107 /s/ Joseph Edelman Joseph Edelman, Managing Member 0001757940
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .